Your browser doesn't support javascript.
loading
Immune Surveillance of Acute Myeloid Leukemia Is Mediated by HLA-Presented Antigens on Leukemia Progenitor Cells.
Nelde, Annika; Schuster, Heiko; Heitmann, Jonas S; Bauer, Jens; Maringer, Yacine; Zwick, Melissa; Volkmer, Jens-Peter; Chen, James Y; Stanger, Anna M Paczulla; Lehmann, Ariane; Appiah, Bismark; Märklin, Melanie; Rücker-Braun, Elke; Salih, Helmut R; Roerden, Malte; Schroeder, Sarah M; Häring, Max-Felix; Schlosser, Andreas; Schetelig, Johannes; Schmitz, Marc; Boerries, Melanie; Köhler, Natalie; Lengerke, Claudia; Majeti, Ravindra; Weissman, Irving L; Rammensee, Hans-Georg; Walz, Juliane S.
Afiliação
  • Nelde A; Department of Peptide-Based Immunotherapy, University and University Hospital Tübingen, Tübingen, Germany.
  • Schuster H; Institute for Cell Biology, Department of Immunology, University of Tübingen, Tübingen, Germany.
  • Heitmann JS; Cluster of Excellence iFIT (EXC2180) "Image-Guided and Functionally Instructed Tumor Therapies", University of Tübingen, Tübingen, Germany.
  • Bauer J; Institute for Cell Biology, Department of Immunology, University of Tübingen, Tübingen, Germany.
  • Maringer Y; Cluster of Excellence iFIT (EXC2180) "Image-Guided and Functionally Instructed Tumor Therapies", University of Tübingen, Tübingen, Germany.
  • Zwick M; Clinical Collaboration Unit Translational Immunology, German Cancer Consortium (DKTK), Department of Internal Medicine, University Hospital Tübingen, Tübingen, Germany.
  • Volkmer JP; Department of Peptide-Based Immunotherapy, University and University Hospital Tübingen, Tübingen, Germany.
  • Chen JY; Institute for Cell Biology, Department of Immunology, University of Tübingen, Tübingen, Germany.
  • Stanger AMP; Cluster of Excellence iFIT (EXC2180) "Image-Guided and Functionally Instructed Tumor Therapies", University of Tübingen, Tübingen, Germany.
  • Lehmann A; Department of Peptide-Based Immunotherapy, University and University Hospital Tübingen, Tübingen, Germany.
  • Appiah B; Institute for Cell Biology, Department of Immunology, University of Tübingen, Tübingen, Germany.
  • Märklin M; Cluster of Excellence iFIT (EXC2180) "Image-Guided and Functionally Instructed Tumor Therapies", University of Tübingen, Tübingen, Germany.
  • Rücker-Braun E; Department of Medicine I, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
  • Salih HR; Institute for Stem Cell Biology and Regenerative Medicine and the Ludwig Cancer Center, Stanford University School of Medicine, Stanford, California.
  • Roerden M; Institute for Stem Cell Biology and Regenerative Medicine and the Ludwig Cancer Center, Stanford University School of Medicine, Stanford, California.
  • Schroeder SM; Department of Hematology, Oncology, Clinical Immunology and Rheumatology, University Hospital Tübingen, Tübingen, Germany.
  • Häring MF; Department of Biomedicine, University of Basel and University Hospital Basel, Basel, Switzerland.
  • Schlosser A; Faculty of Medicine, Medical Center, Institute of Medical Bioinformatics and Systems Medicine (IBSM), University of Freiburg, Germany.
  • Schetelig J; Faculty of Medicine, Medical Center, Institute of Medical Bioinformatics and Systems Medicine (IBSM), University of Freiburg, Germany.
  • Schmitz M; Cluster of Excellence iFIT (EXC2180) "Image-Guided and Functionally Instructed Tumor Therapies", University of Tübingen, Tübingen, Germany.
  • Boerries M; Clinical Collaboration Unit Translational Immunology, German Cancer Consortium (DKTK), Department of Internal Medicine, University Hospital Tübingen, Tübingen, Germany.
  • Köhler N; Department of Medicine I, University Hospital of Dresden, Dresden, Germany.
  • Lengerke C; Center for Regenerative Therapies Dresden, Technische Universität Dresden, Dresden, Germany.
  • Majeti R; Cluster of Excellence iFIT (EXC2180) "Image-Guided and Functionally Instructed Tumor Therapies", University of Tübingen, Tübingen, Germany.
  • Weissman IL; Clinical Collaboration Unit Translational Immunology, German Cancer Consortium (DKTK), Department of Internal Medicine, University Hospital Tübingen, Tübingen, Germany.
  • Rammensee HG; Department of Peptide-Based Immunotherapy, University and University Hospital Tübingen, Tübingen, Germany.
  • Walz JS; Institute for Cell Biology, Department of Immunology, University of Tübingen, Tübingen, Germany.
Blood Cancer Discov ; 4(6): 468-489, 2023 11 01.
Article em En | MEDLINE | ID: mdl-37847741
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Leucemia Mieloide Aguda / Antígenos HLA Limite: Humans Idioma: En Revista: Blood Cancer Discov Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Alemanha
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Leucemia Mieloide Aguda / Antígenos HLA Limite: Humans Idioma: En Revista: Blood Cancer Discov Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Alemanha